EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 20, 2019
Media Advisory: To contact corresponding author Donald A. Redelmeier, M.D., M.S.H.S.R., email Deborah Creatura at email@example.com. The full study, editorial and podcast are linked to this news release.
Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/2733673?guestAccessKey=bf02d03e-cf9a-4beb-8a91-e70ba3d960c0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052019
Bottom Line: Concussion is a common brain injury. This observational study of nearly 29,000 adults (66 and older) diagnosed with concussion examined whether statin use was associated with risk of long-term dementia after a concussion. The analysis compared 7,058 patients who received a statin prescription in the 90 days after a concussion with 21,757 who didn’t. After an average follow-up of four years, 4,727 patients developed dementia (1 in 6). The risk of dementia in older adults after concussion was substantial, and statin use was associated with modestly reduced risk compared to patients who didn’t receive a statin. Limitations of the study include missing information on other factors that could influence the risk of dementia.
Authors: Donald A. Redelmeier, M.D., M.S.H.S.R., University of Toronto, and coauthors
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email firstname.lastname@example.org.